Details about Francesco Saverio Mennini
Access statistics for papers by Francesco Saverio Mennini.
Last updated 2024-02-08. Update your information in the RePEc Author Service.
Short-id: pme934
Jump to Journal Articles
Working Papers
2022
- Approaches to Estimating Indirect Costs in Healthcare: Motivations for Choice
MPRA Paper, University Library of Munich, Germany
2016
- Early treatment in HCV: is it a cost-effective option from the Italian perspective?
CEIS Research Paper, Tor Vergata University, CEIS View citations (2)
2015
- Cost of poor adherence to anti-hypertensive therapy in five European countries
Post-Print, HAL View citations (3)
See also Journal Article Cost of poor adherence to anti-hypertensive therapy in five European countries, The European Journal of Health Economics, Springer (2015) View citations (2) (2015)
- Treatment Plan Comparison in Obstructive Respiratory Disorders: an Observational Study of Doxofylline vs. Theophylline in the Marche Region
CEIS Research Paper, Tor Vergata University, CEIS
2014
- Direct and Indirect Cost of Diabetes in Italy: a Prevalence Probabilistic Approach
CEIS Research Paper, Tor Vergata University, CEIS 
See also Journal Article The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach, The European Journal of Health Economics, Springer (2016) View citations (10) (2016)
- Health Policy Model: Long-term Predictive Results Associated With The Management Of HCV-Induced Diseases In Italy
CEIS Research Paper, Tor Vergata University, CEIS View citations (3)
2013
- Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe
CEIS Research Paper, Tor Vergata University, CEIS
- Economic effects of treatment of chronic kidney disease with low-protein diet
CEIS Research Paper, Tor Vergata University, CEIS View citations (1)
Journal Articles
2023
- COVID-19 Outbreak: A Call to Arms for the World Healthcare Systems
IJERPH, 2023, 20, (24), 1-3
- Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis
The European Journal of Health Economics, 2023, 24, (1), 75-80
2022
- Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis
Applied Health Economics and Health Policy, 2022, 20, (1), 133-143
- Health and Economic Impact of Atrial Fibrillation of Workers in Italy: Social Security Benefits
IJERPH, 2022, 19, (3), 1-8
2021
- An Analysis of the Social and Economic Costs of Breast Cancer in Italy
IJERPH, 2021, 18, (17), 1-12
- Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
Health Economics Review, 2021, 11, (1), 1-10
- Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data
The European Journal of Health Economics, 2021, 22, (9), 1371-1379
2019
- Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data
PharmacoEconomics, 2019, 37, (2), 255-266
- Economic burden of HPV9-related diseases: a real-world cost analysis from Italy
The European Journal of Health Economics, 2019, 20, (6), 829-840 View citations (1)
- Il personale del Servizio Sanitario Nazionale - evoluzione e prospettive nella programmazione sanitaria
MECOSAN, 2019, 2019/110, (110), 9-43
2017
- Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory
Quality & Quantity: International Journal of Methodology, 2017, 51, (3), 1261-1276
- Does regional belonging explain the similarities in the expenditure determinants of Italian healthcare deliveries?
Economic Analysis and Policy, 2017, 55, (C), 47-56 View citations (1)
- Erratum to: Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory
Quality & Quantity: International Journal of Methodology, 2017, 51, (3), 1277-1278
- The perception of corruption in health: AutoCM methods for an international comparison
Quality & Quantity: International Journal of Methodology, 2017, 51, (1), 459-477 View citations (2)
2016
- The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach
The European Journal of Health Economics, 2016, 17, (2), 139-147 View citations (10)
See also Working Paper Direct and Indirect Cost of Diabetes in Italy: a Prevalence Probabilistic Approach, CEIS Research Paper (2014) (2014)
2015
- Cost of poor adherence to anti-hypertensive therapy in five European countries
The European Journal of Health Economics, 2015, 16, (1), 65-72 View citations (2)
See also Working Paper Cost of poor adherence to anti-hypertensive therapy in five European countries, Post-Print (2015) View citations (3) (2015)
- Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country
The European Journal of Health Economics, 2015, 16, (8), 909-911 View citations (2)
2012
- Economic Burden of Human Papillomavirus-Related Diseases in Italy
PLOS ONE, 2012, 7, (11), 1-15 View citations (3)
2005
- Dinamiche determinanti del settore farmaceutico in Europa
L'industria, 2005, (1), 103-118
2003
- Strategie e performance delle grandi aziende farmaceutiche in Italia (1979-2001)
L'industria, 2003, (2), 333-350
- The Welfare States in a United Europe
European Political Economy Review, 2003, 1, (Spring), 40-55 View citations (11)
|
The links between different versions of a paper are constructed automatically by matching on the titles.
Please contact if a link is incorrect.
Use this form
to add links between versions where the titles do not match.
|